Billion-Dollar Deal for Cancer Antibody: BioNTech and Bristol Myers Squibb Join Forces

"...an asset with significant potential for transforming the standard of care for patients with solid tumors"

03-Jun-2025 - BioNTech SE and Bristol Myers Squibb(BMS) announced that the companies have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody BNT327 across numerous solid tumor types. Under the agreement, BioNTech and BMS will work ...

Less cancer through environmentally friendly nutrition?

Link between sustainable diets and cancer risk investigated for the first time

05-May-2025 - In a systematic review and meta-analysis, researchers from the Department of Epidemiology and Preventive Medicine at the University of Regensburg comprehensively investigated the link between sustainable diets and various cancer risks for the first time. The international analysis shows: People ...

4Tissue secures an additional €1.5M in funding

4Tissue appoints Dr. Katleen Verleysen as independent chair of the board.

27-Feb-2025 - 4Tissue, a pioneer in biotechnology that is revolutionizing regenerative medicine, has successfully completed an additional €1.5M funding round, consisting of €1M in equity investments and additional grants. This funding will support the further development of the company’s groundbreaking ...

Dissolving clusters of cancer cells to prevent metastases

Digoxin, a substance found in foxgloven, dissolves clusters of circulating cancer cells in the blood, thus reducing the risk of metastases formation

28-Jan-2025 - Certain tumour types do not remain at their point of origin but spread throughout the body and form metastases. This is because the primary tumour continuously releases cancer cells into the blood. These circulating tumour cells (CTCs) can join together into small clusters of up to a dozen cells ...

Breakthrough: Mini-tumors cultivated from circulating cancer cells for the first time

New approaches against metastatic breast cancer

07-Jan-2025 - Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy resistance difficult. A team from the German Cancer Research Center (DKFZ), the Heidelberg Stem ...

4Tissue raises €2m to advance groundbreaking breast tissue replacement technology

A revolutionary approach

30-Oct-2024 - 4Tissue, a pioneering biotech company revolutionizing regenerative medicine with its cutting-edge, bioresorbable hydrogel tissue mimic has successfully completed a €2M seed funding round including equity investment and non-dilutive grants. Led by three prominent female investors from the life ...

Understanding the physics of cancer, preventing metastases

Jochen Guck receives the Leopoldina Greve Prize

24-Oct-2024 - In honour of his groundbreaking insights into the movement of tumour cells, Professor Dr Jochen Guck from the Max Planck Institute for the Science of Light in Erlangen receives the 2024 Greve Prize from the German National Academy of Sciences Leopoldina. Dealing with metastases is one of the ...

When is the best time of day for cancer treatment?

Researchers are developing new methods to use the internal clock inside tumor cells to optimize cancer therapies

28-Aug-2024 - How effective medications are depends on various factors, including the time of day when they are administered. Why? Because our bodies don’t always function exactly the same. Instead, they follow the cycle set by their internal clock, otherwise known as circadian rhythm. But since each person’s ...

Cancer drug could treat early-stage Alzheimer’s disease, study shows

26-Aug-2024 - A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer’s, according to a recent study by researchers at Penn State, Stanford University and an international team of collaborators. The researchers discovered that by blocking a ...

New target for breast cancer medications

New insights with significant therapeutic potential

22-May-2024 - The mammary gland is a complex tissue comprising a variety of cell types. Their proper functioning is crucial for the health of the breast. Among the numerous factors regulating cell homeostasis in the mammary gland, research has recently focused more intensely on the transcription factor TRPS1. ...